Insights
Clinical insights for GLP-1 prescribers
Evidence-based guidance on running structured GLP-1 services — from pharmacokinetics to patient retention to regulatory compliance.
Food Noise After Stopping GLP-1s: What the Brain Science Shows
Penn Medicine brain imaging reveals why food preoccupation returns after GLP-1 cessation — and what prescribers can do to prepare patients for it.
The Post-Discontinuation Support Gap: An Opportunity for GLP-1 Prescribers
65% of patients stop GLP-1 treatment within a year, yet no competitor offers structured post-treatment support. Here's why that gap is your opportunity.
Restarting GLP-1 Medication: What Prescribers Need to Know About Re-Titration
SmPC restart protocols, gap duration thresholds, drug switching guidance, and a practical checklist for prescribers managing patients who want to resume GLP-1 treatment.
What Happens After Patients Stop GLP-1 Treatment: The Evidence
A comprehensive review of the evidence on weight regain, appetite return, metabolic adaptation, and cardiovascular risk after GLP-1 discontinuation — and why structured support changes outcomes.
Digital Patient Support: The Evidence for Better Adherence
A review of the evidence linking structured digital health interventions to improved medication adherence — and what it means for GLP-1 prescribers.
Nutrition Guidance During GLP-1 Treatment: Evidence-Based Approaches
How to counsel patients on nutrition during GLP-1 treatment — managing reduced appetite, preventing muscle loss, and building sustainable habits.
How Prescribers Can Compete in the GLP-1 Market
The GLP-1 market is growing fast. Here's how independent prescribers can differentiate their service and build a sustainable weight management business.
The First Two Weeks on Mounjaro: What Patients Actually Experience
A week-by-week guide to what patients can expect during their first fortnight on tirzepatide — from injection technique to side effect timelines.
MHRA Registration for Digital Health Tools: What Prescribers Should Know
A guide to MHRA classification, UKCA marking, and what to look for when choosing digital health tools for your GLP-1 service.
Patient-Reported Outcomes: Why Your GLP-1 Service Needs Structured Data
How capturing structured patient-reported outcomes transforms your GLP-1 service from dispensing-only to a data-driven clinical programme.
The Pharmacokinetics of Semaglutide: Why Timing Matters
Understanding semaglutide's absorption, distribution, and elimination — and why pharmacokinetic awareness improves patient counselling.
Building a Weight Management Service: A Practical Guide for Prescribers
How to set up and run a profitable, clinically sound GLP-1 weight management service — whether you're a pharmacy, clinic, or private practice.
Why Patients Drop Off GLP-1 Treatment — And How to Keep Them
GLP-1 dropout rates are high across all prescriber settings. Here's what drives patients away and what structured support can do about it.
Managing GLP-1 Side Effects: What to Tell Your Patients
Practical guidance on managing the most common GLP-1 side effects — nausea, constipation, injection site reactions — and when to escalate.
Semaglutide vs Tirzepatide: Key Differences for Prescribers
A head-to-head comparison of semaglutide and tirzepatide — pharmacology, efficacy data, side effect profiles, and practical prescribing considerations.
What Are GLP-1 Receptor Agonists? A Prescriber's Guide
A clinical overview of GLP-1 receptor agonists — how they work, current approved indications, and what prescribers need to know about semaglutide and tirzepatide.